Chattem Settles Dexatrim-Related Stroke Case for $3.5 Million




CHATANOOGA, Tenn. - Chattem, Inc., the manufacturer of Dexatrim, announced that it will pay $3.5 million to settle a suit filed by a Texas woman who allegedly suffered a hemorrhagic stroke after taking the PPA-containing drug. Jennifer Villarreal, et al., v. Chattem, Inc., et al., No. N/A (Texas Dist. Ct., Brazoria Cty.).

The case was scheduled to go to trial May 19 in the District Court of Brazoria County, Texas.

According to a statement the drug maker issued May 7, the company is pleased with the terms of the agreement and the settlement amount will be funded by the company's …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS